4//SEC Filing
Patni Rajiv 4
Accession 0001209191-23-037021
CIK 0001358762other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:26 PM ET
Size
7.4 KB
Accession
0001209191-23-037021
Insider Transaction Report
Form 4
Patni Rajiv
EVP, Chief R&D Officer
Transactions
- Award
Class A common stock
2023-06-12+45,000→ 45,000 total - Award
Employee Stock Option (right-to-buy)
2023-06-12+90,000→ 90,000 totalExercise: $99.12Exp: 2033-06-12→ Class A common stock (90,000 underlying)
Footnotes (2)
- [F1]The shares represent Restricted Stock Units, which vest as to 11,250 shares on June 12, 2024, with the remainder to vest in twelve equal quarterly installments thereafter, subject to continued service through each vesting date.
- [F2]The option, representing a right to purchase a total of 90,000 Class A shares, become exercisable as to 22,500 on June 12, 2024, with the remainder to vest in twelve equal quarterly installments thereafter, subject to continued service through each vesting date.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001616200
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:26 PM ET
- Size
- 7.4 KB